Key Account Director, Diagnostics and Research
Tempus AI
Summary
Tempus is seeking a Key Account Director to join its Life Sciences Diagnostics (Dx) and Research Services team, focused on creating and expanding global client relationships with leading biopharmaceutical organizations, with central emphasis on hereditary business, rare diseases, and cardiovascular conditions.
Job description
Responsibilities
- Develop and drive global account strategy in coordination with scientific and business operations teams focused on rare diseases and cardiovascular conditions
- Meet and exceed revenue goals for Tempus Dx product lines while delivering on strategic objectives for specific client accounts
- Build and maintain executive and R&D relationships and drive CXO strategy leveraging Tempus senior leadership
- Become an expert in the partner's strategy, pipeline and portfolio to determine all areas the Tempus platform could be leveraged
- Negotiate, secure and manage pull-through of contracts with assigned client accounts
- Align cross-functional team of Product Specialists, partner Key Account Directors, Translational Researchers and Commercial Operations
- Partner with clients to develop and announce impactful case studies leveraging the Tempus Dx platform
- Contribute to development of the Life Sciences portfolio by providing feedback to Leadership
- Track progress against defined strategic objectives and revenue goals
- Travel approximately 30% of working time, domestically and internationally
Qualifications
- Entrepreneurial sales approach; thrives in a high growth, rapidly evolving business environment
- Proactive mindset that bridges ideas to implementable solutions
- Deep relationships with pharmaceutical stakeholders
- Deep understanding of NGS and IHC technologies, as well as drug development lifecycles
- Proven ability to navigate multi-faceted client organizations
- Ability to set aggressive but realizable strategies/tactics
- Demonstrated ability to influence without authority
- Learning agility to adapt to a rapidly changing environment
- Exceptional account management and stakeholder navigation skills
Experience
- Minimum of 10 years of experience in Business Development and Sales within the Life Sciences sector, serving as the primary account and manager (Pharma/Biotech)
- Ideally, 5+ years of experience working with organizations that support Life Sciences companies in R&D and/or diagnostic solutions used in clinical trial selection
- Strong knowledge of drug and diagnostic regulatory approval processes, both in the U.S. and internationally
- Deep understanding of clinical trial design, execution, and timelines
- Demonstrated ability to build trust and credibility with clients, acting as a strategic advisor
- Proven success in negotiating and closing large, complex, multi-year agreements
- Bachelor degree in a Science or Business discipline; Advanced degree (MBA, PhD or Healthcare certification) desired
Requirements
- Minimum of 10 years of experience in Business Development and Sales within the Life Sciences sector
- Bachelor degree in a Science or Business discipline
- Deep understanding of NGS and IHC technologies
- Deep understanding of drug development lifecycles
- Strong knowledge of drug and diagnostic regulatory approval processes, both in the U.S. and internationally
- Deep understanding of clinical trial design, execution, and timelines
- Proven success in negotiating and closing large, complex, multi-year agreements
- Deep relationships with pharmaceutical stakeholders
- Demonstrated ability to influence without authority
- Advanced degree (MBA, PhD or Healthcare certification) desired
- Ideally, 5+ years of experience working with organizations that support Life Sciences companies in R&D and/or diagnostic solutions used in clinical trial selection
Benefits
- Incentive Compensation
- Restricted Stock Units
- Medical Benefits
Company overview
Tempus AI, Inc. (NASDAQ: TEM) is a pioneering healthcare technology company founded in 2015 by Eric Lefkofsky in Chicago, Illinois. The company was established after Lefkofsky's wife was diagnosed with breast cancer, driving his mission to revolutionize cancer care through technology and artificial intelligence. Tempus specializes in applying AI to advance precision medicine by collecting and analyzing vast amounts of molecular, clinical, and genomic data. The company operates across multiple therapeutic areas including oncology, cardiology, radiology, neurology, psychiatry, and dermatology. Tempus provides comprehensive diagnostic services including next-generation sequencing (NGS), PCR profiling, and molecular pathology testing. Its AI-powered platform enables physicians to make real-time, data-driven decisions for personalized patient care and targeted therapies. The company went public in June 2024 and has expanded globally with operations in multiple countries. Tempus continues to innovate at the intersection of healthcare and artificial intelligence, aiming to ensure patients receive the right treatments at the right time for improved health outcomes.